The gene gun: current applications in cutaneous gene therapy

Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 12 Epidermolytic PPK KRT9 12 Non-epidermolytic PPK KRT16 12 Vohwinkel’s syndrome LOR 31 Ichthyosis bullosa Siemens KRT2e 64 Pachonychia congenita type 1/2 KRT6a, 16, 17 64 X-linked ichthyosis STS 7 Lamellar ichthyosis TGM1 31 Palmoplantar keratoderma GJB2 61 with deafness Erythrokeratodermia variabilis GJB3 60 Darier’s disease ATP2A2 66 Striate palmoplantar keratoderma DSP 2 Striate keratoderma DSG1 62

[1]  P. Ingham,et al.  The patched gene in development and cancer. , 1998, Current opinion in genetics & development.

[2]  Murphy The cutaneous porphyrias: a review , 1999, The British journal of dermatology.

[3]  Massimo Pandolfo,et al.  Molecular Basis , 2022 .

[4]  I. Leigh,et al.  Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. , 1999, Human molecular genetics.

[5]  W. McLean,et al.  Human keratin diseases: , 1996, Experimental dermatology.

[6]  R. Purcell,et al.  DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Iizuka,et al.  Structural organization of cornified cell envelopes and alterations in inherited skin disorders , 1998, Experimental dermatology.

[8]  S. Rosenberg,et al.  Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. , 1996, Journal of immunology.

[9]  J. Morgan,et al.  Biologic aspects of expression of stably integrated transgenes in cells of the skin in vitro and in vivo. , 1999, Proceedings of the Association of American Physicians.

[10]  H. van Steeg,et al.  Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. , 1999, Molecular medicine today.

[11]  F. Elgh,et al.  DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection. , 1999, Virology.

[12]  C. Eng,et al.  Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.

[13]  C. Eng Genetics of Cowden syndrome: through the looking glass of oncology. , 1998, International journal of oncology.

[14]  D. Jolly Viral vector systems for gene therapy. , 1994, Cancer gene therapy.

[15]  J. Ott,et al.  Exposing the human nude phenotype , 1999, Nature.

[16]  A. Gambotto,et al.  Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models , 1997, Gene Therapy.

[17]  A. Marrogi,et al.  In situ use of suicide genes for cancer therapy. , 1996, Seminars in oncology.

[18]  S. Bale,et al.  Patching Together the Genetics of Gorlin Syndrome , 1998, Journal of cutaneous medicine and surgery.

[19]  N. Craddock,et al.  Mutations in ATP2A2, encoding a Ca2+ pump, cause Darier disease , 1999, Nature Genetics.

[20]  S. Rosenberg,et al.  Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. , 1996, Journal of immunology.

[21]  N. Yang,et al.  In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Vile,et al.  Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. , 1994, Cancer research.

[23]  James J. Nordlund,et al.  THE PIGMENTARY SYSTEM , 1985 .

[24]  I. Mackenzie,et al.  Retroviral transduction of murine epidermal stem cells demonstrates clonal units of epidermal structure. , 1997, The Journal of investigative dermatology.

[25]  Lee,et al.  Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. , 1998, Cancer research.

[26]  R. Vile,et al.  Targeted therapy for malignant melanoma. , 1994, Current opinion in oncology.

[27]  D. Mahvi,et al.  Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine. , 1996, Human gene therapy.

[28]  T. Klein,et al.  Transformation of Microbes, Plants and Animals by Particle Bombardment , 1992, Bio/Technology.

[29]  S. Bale,et al.  Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis , 1998, Nature Genetics.

[30]  D. Curiel,et al.  Selected strategies to augment polynucleotide immunization. , 1996, Gene therapy.

[31]  J. Fine Epidermolysis Bullosa. Clinical, Epidemiologic, and Laboratory Advances and the Findings of the National Epidermolysis Bullosa Registry , 2000 .

[32]  D. Curiel,et al.  Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. , 1994, Human gene therapy.

[33]  J. Haynes,et al.  Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery , 1996, Journal of virology.

[34]  E. D. Wolf,et al.  High-velocity microprojectiles for delivering nucleic acids into living cells , 1987, Nature.

[35]  D. Weiner,et al.  In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunization , 1996, Journal of medical primatology.

[36]  A. Messenger,et al.  A mutational hotspot in the 2B domain of human hair basic keratin 6 (hHb6) in monilethrix patients. , 1998, The Journal of investigative dermatology.

[37]  A. Rosenberg,et al.  Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid. , 1999, Human gene therapy.

[38]  N. B. Ray,et al.  Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. , 1998, Vaccine.

[39]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[40]  Z. Ram,et al.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. , 1992, Science.

[41]  J. Uitto,et al.  Hemidesmosomal variants of epidermolysis bullosa , 1998 .

[42]  W. Bodmer,et al.  Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. , 1999, The Journal of investigative dermatology.

[43]  Y W Kan,et al.  Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Fuchs,et al.  Transgenic studies with a keratin promoter-driven growth hormone transgene: prospects for gene therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Ting,et al.  Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  L. Goldsmith,et al.  Topical application of viral vectors for epidermal gene transfer. , 1997, The Journal of investigative dermatology.

[47]  C. Richards,et al.  Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[48]  D. Roop,et al.  Epidermis: an attractive target tissue for gene therapy. , 1994, The Journal of investigative dermatology.

[49]  M. Lussier,et al.  Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. , 1996, Journal of cell science.

[50]  E. Lane,et al.  Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome , 1997, Nature Genetics.

[51]  L. Goldsmith,et al.  A model for keratinocyte gene therapy: preclinical and therapeutic considerations. , 1996, Proceedings of the Association of American Physicians.

[52]  N. Yang,et al.  In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[53]  O. Evgrafov,et al.  Bacterial β‐galactosidase and human dystrophin genes are expressed in mouse skeletal muscle fibers after ballistic transfection , 1997, FEBS letters.

[54]  O. V. Tarasenko,et al.  [Expression of the human dystrophin gene in mdx mouse skeletal muscles after ballistic transfection]. , 1998, Genetika.

[55]  L. Falo,et al.  Targeting the skin for genetic immunization. , 1999, Proceedings of the Association of American Physicians.

[56]  S. Johnston,et al.  Protection against Mycoplasma pulmonis infection by genetic vaccination. , 1995, DNA and cell biology.

[57]  T. Tüting,et al.  DNA immunization targeting the skin: molecular control of adaptive immunity. , 1998, The Journal of investigative dermatology.

[58]  E. Fuchs,et al.  Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice , 1993, Molecular and cellular biology.

[59]  P. Jahrling,et al.  DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. , 1998, Virology.

[60]  J. Uitto,et al.  Cutaneous gene therapy. Principles and prospects. , 2000, Dermatologic clinics.

[61]  J. Nordlund,et al.  Molecular basis of congenital hypopigmentary disorders in humans: a review. , 1997, Pigment cell research.

[62]  J. Garlick,et al.  Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[63]  T. Pugh,et al.  In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[64]  N. Yang,et al.  Gene gun-mediated IL-12 gene therapy induces antitumor effects in the absence of toxicity: a direct comparison with systemic IL-12 protein therapy. , 1999, Journal of immunotherapy.

[65]  J. Ott,et al.  Alopecia universalis associated with a mutation in the human hairless gene. , 1998, Science.

[66]  S. Burdach,et al.  Combined chemokine and cytokine gene transfer enhances antitumor immunity , 1996, Nature Medicine.

[67]  W. Abler The Teeth of the Tyrannosaurs , 1999 .

[68]  J. Shapiro,et al.  Alopecia: unapproved treatments or indications. , 2000, Clinics in dermatology.

[69]  J. Uitto,et al.  Plectin and human genetic disorders of the skin and muscle , 1996, Experimental dermatology.

[70]  E. Nabel,et al.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[71]  N. Yang,et al.  Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. , 1996, Gene therapy.

[72]  W. Kao,et al.  Identification of the cornea-specific keratin 12 promoter by in vivo particle-mediated gene transfer. , 1998, Investigative ophthalmology & visual science.

[73]  J. Nordlund The pigmentary system : physiology and pathophysiology , 1998 .

[74]  H. Winter,et al.  Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix , 1997, Nature Genetics.

[75]  Thomas W. White,et al.  Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma , 1998, Human Genetics.

[76]  S. Johnston,et al.  Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[77]  D. Kelsell,et al.  N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. , 1999, Human molecular genetics.

[78]  D. Drew,et al.  Humoral responses in mice following vaccination with DNA encoding glutathione S‐transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression , 1999, Parasite immunology.

[79]  S. Freeman,et al.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. , 1993, Cancer research.

[80]  J. Vogel A direct in vivo approach for skin gene therapy. , 1999, Proceedings of the Association of American Physicians.

[81]  D. Marchuk Genetic abnormalities in hereditary hemorrhagic telangiectasia , 1998, Current opinion in hematology.

[82]  D. Roop,et al.  Transduction of a preselected population of human epidermal stem cells: consequences for gene therapy. , 1999, Proceedings of the Association of American Physicians.

[83]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.